Clinical Trials Sponsored by Case Comprehensive Cancer Center

Total 3625 results

Case Comprehensive Cancer Center

Completed

Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma

United States
Case Comprehensive Cancer Center

Completed

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma

United States
Case Comprehensive Cancer Center

Withdrawn

Pembrolizumab With Axitinib in Recurrent Endometrial Cancer

Recurrent Endometrial Cancer
Case Comprehensive Cancer Center

Terminated

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Stage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Stage II Endometrial Carcinoma | Stage I Endometrial Carcinoma

United States
Case Comprehensive Cancer Center

Completed

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Brain and Central Nervous System Tumors | Metastatic Cancer | Radiation Toxicity

United States
Case Comprehensive Cancer Center

Completed

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Colorectal Cancer

United States
Case Comprehensive Cancer Center

Terminated

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

Breast Cancer | Colorectal Cancer | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment

United States
Case Comprehensive Cancer Center

Completed

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases

United States
Case Comprehensive Cancer Center

Completed

Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer

Breast Cancer

United States
Case Comprehensive Cancer Center

Completed

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
Case Comprehensive Cancer Center

Terminated

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma

Primary Central Nervous System Non-Hodgkin Lymphoma

United States
Case Comprehensive Cancer Center

Completed

Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission

Endometrial Cancer | Weight Changes

United States
Case Comprehensive Cancer Center

Completed

Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
Case Comprehensive Cancer Center

Withdrawn

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Breast Cancer
Case Comprehensive Cancer Center

Withdrawn

Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

Uterine Cancer
Case Comprehensive Cancer Center

Completed

End Nicotine Dependence Clinic

Smoking Cessation

United States
Case Comprehensive Cancer Center

Completed

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

Prostate Cancer

United States
Case Comprehensive Cancer Center

Completed

Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening

Prostate Cancer

United States
Case Comprehensive Cancer Center

Completed

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Prostate Cancer

United States
Case Comprehensive Cancer Center

Withdrawn

A Study of the Use of AirXpanders AeroForm in Patients Undergoing Post-Mastectomy Radiation Therapy

Breast Cancer
Case Comprehensive Cancer Center

Completed

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Cancer | Solid Tumor

United States
Case Comprehensive Cancer Center

Completed

Path2Quit Tobacco Intervention For African Americans

Smoking Cessation | Smoking, Tobacco

United States
Case Comprehensive Cancer Center

Completed

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Recurrent Intraocular Melanoma

United States
Case Comprehensive Cancer Center

Completed

Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer

Head and Neck Cancer

United States
Case Comprehensive Cancer Center

Withdrawn

Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer

Breast Reconstruction | Mastectomy

United States
Case Comprehensive Cancer Center

Completed

Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus

Short Segment Barrett's Esophagus | Long Segment Barrett's Esophagus

United States
Case Comprehensive Cancer Center

Withdrawn

Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography

Breast Cancer
Case Comprehensive Cancer Center

Terminated

A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer

Any Cancer Diagnosis

United States
Case Comprehensive Cancer Center

Withdrawn

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Castrate-resistant Metastatic Prostate Cancer
Case Comprehensive Cancer Center

Completed

Exercising Our ABC's (African- American Breast Cancer Survivors)

Breast Cancer

United States
Case Comprehensive Cancer Center

Completed

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Renal Cell Cancer | Stage IV Renal Cell Cancer

United States
Case Comprehensive Cancer Center

Terminated

Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

Rectal Cancer | Colon Cancer

United States
Case Comprehensive Cancer Center
Cephalon

Terminated

Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
Case Comprehensive Cancer Center
GlaxoSmithKline

Completed

Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer

Prostate Cancer

United States
Case Comprehensive Cancer Center
Pfizer

Terminated

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Recurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder

United States
Jack Khouri

Not yet recruiting

Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Multiple Myeloma | Refractory Multiple Myeloma | Cytokine Release Syndrome | Immune Effector Cell Associated Neurotoxicity Syndrome

United States
Luminary Therapeutics
Case Comprehensive Cancer Center

Recruiting

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin Lymphoma, B-Cell

United States
Benjamin Tomlinson

Recruiting

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Myelodysplastic Syndromes | MDS/MPN Crossover Syndromes

United States
Mari Dallas

Recruiting

T Cell Therapy of Opportunistic Cytomegalovirus Infection

Cytomegalovirus Infections | Opportunistic Infections | Hematopoietic Stem Cell Transplant

United States
David Bajor

Active, not recruiting

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Deepa Jagadeesh
Case Comprehensive Cancer Center

Active, not recruiting

ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

United States
Benjamin Tomlinson

Active, not recruiting

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Non-Hodgkin Lymphoma

United States
David Peereboom

Active, not recruiting

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Recurrent Glioblastoma

United States
Brian Hill

Recruiting

Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma

United States
Benjamin Tomlinson

Recruiting

Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

United States
Leland Metheny

Not yet recruiting

Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT

Lymphoproliferative Disorders | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Allogeneic Stem Cell Transplant Candidate | Acute Myeloid/Lymphoblastic Leukemia

United States
Mari Dallas

Recruiting

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation

United States
Sudipto Mukherjee

Active, not recruiting

Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | AML

United States
Deepa Jagadeesh

Terminated

Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder

Post-transplant Lymphoproliferative Disorder

United States
Moshe Ornstein

Completed

Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma

United States

Clinical Trials Sponsored by Case Comprehensive Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations